[ Thymox Technology raises $4.6M in Series B ]

Thymox Technology has raised $4.6 million in Series B funding.

Founded in 2003, Laboratoire M2 has a well-respected reputation for product innovation and expertise in environmentally sustainable, green disinfection and bio-security technology under the trademark THYMOX™. Its line of animal health products includes THYMOX HOOF® which is used on dairy cows as an aid to control digital dermatitis (DD). THYMOX™ also distributes products and ingredients under private label agreements in institutional, retail, and crop protection markets.

The funds will primarily be used to accelerate international commercial expansion of THYMOX™ as a disinfectant for animal health and crop protection, and into institutional and retail markets.

Funding  Series B
Founded  2003
Country  Canada
City  Sherbrooke, Quebec
Founder / CEO  Frank Palantoni
Deal Size  $4.6M
Investors  Germain Benoit
 Cycle Capital
 Desjardins-Innovatech
Previous Investors  /